ArticleFrontiers in oncology2025
Case Report: A case of new-onset retroperitoneal aggressive fibromatosis after resection of solid pseudopapillary tumor of the pancreas and review of the literature.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aggressive fibromatosis is a rare tumor known for its intensive local invasion and postoperative recurrence. Tumors may occur incidentally or be associated with familial adenomatous polyposis. We report a case of new aggressive fibromatosis after removal of solid pseudopapillary tumor of pancreas. The patient underwent two laparotomies, the first one was radical resection, and the second was R1 resection due to invasive fibromatosis invading the surrounding blood vessels, and titanium clips were indwelled at the resection margin for further radiotherapy treatment. Both pathological diagnoses of the patients were confirmed. There have been no previous reports of a relationship between solid pseudopapillary tumor of the pancreas and aggressive fibromatosis. We believe that surgical R0 resection should continue to be sought after surgery. If there is recurrence or metastasis, radiotherapy or targeted drug therapy such as sorafenib (400 mg/day) should be performed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.